These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23912348)

  • 1. [Current status of GVHD prophylaxis using anti-thymocyte globulin in Japan].
    Fuji S; Fukuda T
    Rinsho Ketsueki; 2013 Jul; 54(7):649-52. PubMed ID: 23912348
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts.
    Weiden PL; Doney K; Storb R; Thomas ED
    Transplant Proc; 1978 Mar; 10(1):213-6. PubMed ID: 345561
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of acute graft-versus-host disease.
    Deeg HJ; Henslee-Downey PJ
    Bone Marrow Transplant; 1990 Jul; 6(1):1-8. PubMed ID: 2202460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation.
    Lynch BA; Vasef MA; Comito M; Gilman AL; Lee N; Ritchie J; Rumelhart S; Holida M; Goldman F
    Bone Marrow Transplant; 2003 Sep; 32(5):527-33. PubMed ID: 12942101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute graft-versus-host disease in thalassaemic marrow transplantation with low-dose antithymocyte globulin.
    Khojasteh HN; Zakerinia M; Ramzi M; Haghshenas M
    East Mediterr Health J; 1999 May; 5(3):465-9. PubMed ID: 10793825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical trial of antithymocyte globulin for prophylaxis of acute graft-versus-host disease in pediatric recipients of bone marrow transplantation from unrelated donors].
    Yagasaki H; Kojima S; Inaba J; Kato K; Matsuyama T
    Rinsho Ketsueki; 1999 May; 40(5):382-9. PubMed ID: 10390886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-thymocyte globulin for immunosuppression].
    Collste LG; Franksson C; Groth CG; Jacobson S; Magnusson G; Schantz B; Svehag SE; Werner B
    Nord Med; 1971; 86(46):1358. PubMed ID: 4944024
    [No Abstract]   [Full Text] [Related]  

  • 8. Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
    Rosenbeck LL; Kiel PJ; Kalsekar I; Vargo C; Baute J; Sullivan CK; Wood L; Abdelqader S; Schwartz J; Srivastava S; Abonour R; Robertson MJ; Nelson RP; Cornetta K; Fausel CA; Farag SS
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):916-22. PubMed ID: 20932925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical uses of anti-thymocyte globulin (ATGAM), Part II.
    Gilbert C
    N C Med J; 1984 Dec; 45(12):773-5. PubMed ID: 6392895
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
    Zander AR; Zabelina T; Kröger N; Renges H; Krüger W; Löliger C; Dürken M; Stockschläder M; de Wit M; Wacker-Backhaus G; Bielack S; Jaburg N; Rüssmann B; Erttmann R; Kabisch H
    Bone Marrow Transplant; 1999 May; 23(9):889-93. PubMed ID: 10338043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effect of reduced-intensity conditioning regimen containing antithymocyte globulin for hematopoietic cell transplantation from unrelated-donors.
    Lee KH; Choi SJ; Lee JH; Lee JH; Kim DY; Seol M; Lee YS; Kang YA; Jeon M; Yun SC; Joo YD; Lee WS; Kang MJ; Kim H; Park JH; Bae SH; Ryoo HM; Kim MK; Hyun MS
    Am J Hematol; 2011 May; 86(5):399-405. PubMed ID: 21523798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mini-transplantation from HLA-mismatched donors].
    Ogawa H
    Nihon Rinsho; 2003 Sep; 61(9):1549-54. PubMed ID: 14515722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic prophylaxis of acute graft-versus-host disease after allogeneic marrow transplantation.
    Schwinghammer TL; Bloom EJ
    Clin Pharm; 1993 Oct; 12(10):736-61. PubMed ID: 8258255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.
    Ayuk F; Diyachenko G; Zabelina T; Panse J; Wolschke C; Eiermann T; Binder T; Fehse B; Erttmann R; Kabisch H; Bacher U; Kröger N; Zander AR
    Exp Hematol; 2008 Aug; 36(8):1047-54. PubMed ID: 18456390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life of patients after allogeneic hematopoietic stem cell transplantation with antihuman thymocyte globulin.
    Yu ZP; Ding JH; Wu F; Liu J; Wang J; Cheng J; Zhao G
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):593-9. PubMed ID: 21846461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone marrow transplantation for severe aplastic anemia].
    Bullorsky EO; Bonduel M; Shanley C; Figueroa C; Stemmelin G; Del Pozo A; Ceresetto J; Delfino S; Puppo M; Muriel FS
    Medicina (B Aires); 1998; 58(2):130-4. PubMed ID: 9706244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in umbilical cord transplantation: the role of thymoglobulin/ATG in cord blood transplantation.
    Mohty M; Gaugler B
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):275-82. PubMed ID: 20837339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M; Khojasteh HN; Ramzi M; Haghshenas M
    Transplant Proc; 2005 Dec; 37(10):4477-81. PubMed ID: 16387149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunosuppressive drugs in the prevention and treatment of GVHD after allogenic bone marrow transplantation].
    Basić-Jukić N; Labar B
    Acta Med Croatica; 2003; 57(2):131-9. PubMed ID: 12879693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low incidence of hyperacute graft-versus-host disease (GVHD) with effective GVHD prophylaxis based on anti-thymocyte globulin.
    Radici V; Stocker N; Dulery R; Brissot E; Bannet A; van de Wyngaert Z; Sestili S; Belhocine R; Bonin A; Ledraa T; Mohty M; Malard F
    Br J Haematol; 2022 Jun; 197(5):630-633. PubMed ID: 35245388
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.